Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Demand has recovered quickly and the science kit maker is taking advantage of this opportunity
Thursday 11 Nov 2021 Author: Steven Frazer

SDI (SDI:AIM) 217p
Gain to date: 23.7%
Original entry point: Buy at 174.5p, 27 May 2021

As pandemic recoveries go SDI’s (SDI:AIM) should be counted as very encouraging by investors. A 4 November half-year update revealed that the science kit maker expects ‘very strong sales and profits’ with approximately £24.7 million in revenue. That’s just £800,000 less than it did in the whole of last year, albeit a Covid capped one.

Part of this boost can be explained by a stronger-than-expected performance from Monmouth Scientific, bought last December, slightly higher Atik sales but largely from broad-based growth across its businesses.

SDI is a collection of multiple subsidiaries that design and manufacture digital imaging, sensing and control equipment used in life sciences, healthcare, astronomy, manufacturing and other technology-heavy industries.

Analysts responded to the latest update by increasing expectations by mid-single digits for the next two financial years. While it is not yet clear if first half sales strength was simply a pull forward, ‘if not, it offers scope potentially for upgrades later in the year,’ says FinnCap.

Shares previously said SDI represented a multi-year growth story with the potential to add substantial value to retail investor portfolios and that optimism remains undimmed now.

SHARES SAYS: SDI remains a great growth stock to own.

‹ Previous2021-11-11Next ›